Streetbeat News

Products Services

AADR

E

IDGT

Eni S.p.A. (NYSE:E) shares are trading lower today due to plans to sell minority stakes in its biofuel and bio-plastic units by year-end, aiming to raise EUR1.3 billion. Preliminary discussions are underway with potential partners for up to 10% of the biofuel unit, Enilive, which could be valued at over EUR10 billion, including debt. Options for Enilive include an IPO or a spin-off. Eni is also negotiating the sale of up to 30% of its bio-plastic business, Novamont, potentially valued at around EUR1 billion. These moves are part of Eni's strategy to fund greener businesses without impacting its oil and gas operations.

Portfolio Pulse from Lekha Gupta

April 16, 2024 | 11:36 am

PRZO

ParaZero announced its entry into the Counter Unmanned Aircraft System market, signaling a strategic expansion of its business operations.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:35 am

CYBN

Cybin announced the grant of an additional US patent supporting its CYB003 program for Major Depressive Disorder, potentially strengthening its intellectual property and therapeutic offering.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:35 am

ENVX

Enovix Corporation (NASDAQ:ENVX), a leading battery company, has successfully completed Factory Acceptance Testing for its Gen2 Agility Line and plans to produce its first silicon battery samples in Q2 2024 from its new factory, Fab2. This marks a significant step in utilizing a 100% active silicon anode for higher energy density in batteries, aimed at mobile and IoT markets.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:34 am

LILM

Lilium N.V. (NASDAQ:LILM) has initiated the production of advanced, aviation-grade battery packs for its pioneering all-electric eVTOL Lilium Jet, aiming for a piloted flight by the end of 2024. These batteries feature lithium-ion cells with silicon-dominant anodes for enhanced energy, power, and fast-charging capabilities, aligning with the technology planned for use by leading automakers. The production meets EASA's strict safety standards and supports a regional air mobility business model. Lilium's battery factory near Munich utilizes new generation digital tools for efficient production and has secured comprehensive IP rights for its battery technology.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:33 am

LXEO

Lexeo Therapeutics has received FDA Fast Track Designation for LX2006, an AAV-based gene therapy candidate aimed at treating Friedreich's Ataxia Cardiomyopathy. This designation could accelerate the development and review process for LX2006, potentially bringing it to patients sooner.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:31 am

DJT

Trump Media & Technology Group's shares surged following the announcement of its upcoming streaming platform launch.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:25 am

CVAC

CureVac and MD Anderson have announced a strategic collaboration to develop novel cancer vaccines, aiming to leverage CureVac's mRNA technology for cancer treatment advancements.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:21 am

BTCY

Biotricity Inc. has initiated a pilot program for cardiac monitoring in collaboration with a major hospital network. This move represents a significant step for Biotricity in expanding its reach and testing its technology in real-world healthcare settings. The partnership with a prominent hospital network could potentially enhance Biotricity's market presence and credibility in the medical technology sector.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:10 am

BLK

Markus Thielen of 10X Research, known for accurately predicting Bitcoin's rise, now forecasts a downturn in risk assets, including tech stocks and cryptocurrencies, due to persistent inflation and higher bond yields. Thielen has sold all tech stocks and reduced crypto holdings, citing poor Nasdaq performance and challenging interest rate cut expectations. The adjustment in Fed rate cut expectations and a high 10-year Treasury yield are diminishing the appeal of riskier investments. Despite a 42% YTD gain for Bitcoin and a 17% rise in the CoinDesk 20 Index, the market faces uncertainty, especially with the upcoming Bitcoin halving event.

Portfolio Pulse from Benzinga Neuro

April 16, 2024 | 11:09 am